Your browser doesn't support javascript.
loading
Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis.
Zanga, Gisela; Drzewiscki, Estefania; Tagliani, Paula; Smietniansky, Maximiliano; Esnaola Y Rojas, Maria M; Caruso, Diego.
Affiliation
  • Zanga G; Department of Neurology, César Milstein Hospital, associated with University of Buenos Aires, La Rioja 951, Buenos Aires, C1221ACI, Argentina.
  • Drzewiscki E; Department of Neurology, César Milstein Hospital, associated with University of Buenos Aires, Buenos Aires, Argentina.
  • Tagliani P; Servei de Neurologia-Neuroinmunologia, Centre d'Esclerosi Multiple de Catalunya, (CEMCAT), Vall d'Hebron Hospital Universitari, Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Smietniansky M; Department of Internal Medicine Interna, Programa de Medicine Geriatric Program, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Esnaola Y Rojas MM; Department of Neurology, César Milstein Hospital, associated with University of Buenos Aires, Buenos Aires, Argentina.
  • Caruso D; Department of Internal Medicine, César Milstein Hospital, associated with University of Buenos Aires, Buenos Aires, Argentina.
Ther Adv Neurol Disord ; 14: 17562864211031099, 2021.
Article in En | MEDLINE | ID: mdl-34630632
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Ther Adv Neurol Disord Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Ther Adv Neurol Disord Year: 2021 Document type: Article Affiliation country: Country of publication: